Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Germ Cell Neoplasia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02423863
What this trial is testing

In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol®

Who this might be right for
MelanomaHead and Neck CancerSarcoma+1 more
Oncovir, Inc. 26
Large-scale testing (Phase 3)UnknownNCT03025893
What this trial is testing

A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma MultiformeGlioblastoma, AdultGlioblastoma+2 more
Amsterdam UMC, location VUmc 100
Very early researchWithdrawnNCT04051047
What this trial is testing

Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma

Who this might be right for
Glial Tumor of BrainDiffuse Intrinsic Pontine GliomaGlioma
University of Michigan Rogel Cancer Center
Not applicableUnknownNCT06045065
What this trial is testing

Preclinical Brain Tumor Models

Who this might be right for
Brain MetastasesDiffuse Gliomas
Assistance Publique Hopitaux De Marseille 60
Testing effectiveness (Phase 2)Study completedNCT01846871
What this trial is testing

Tivozanib for Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Massachusetts General Hospital 10
Testing effectiveness (Phase 2)UnknownNCT04427787
What this trial is testing

A Trial Aiming to Assess the Safety and Activity of the Combination of Cabozantinib Plus Lanreotide in GEP and NET

Who this might be right for
Metastatic Well Differentiated Neuroendocrine NeoplasmNeuroendocrine Tumors
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 69
Early research (Phase 1)Ended earlyNCT01810016
What this trial is testing

NY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic Melanoma

Who this might be right for
Unresectable or Metastatic Melanoma
Ludwig Institute for Cancer Research 8
Testing effectiveness (Phase 2)UnknownNCT04874506
What this trial is testing

MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM)

Who this might be right for
GlioblastomaGlioblastoma Multiforme
Matrix Biomed, Inc. 55
Testing effectiveness (Phase 2)Study completedNCT03110744
What this trial is testing

CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma

Who this might be right for
Chordoma
University Hospital Heidelberg 43
Testing effectiveness (Phase 2)Looking for participantsNCT01804634
What this trial is testing

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Who this might be right for
Refractory and/or Relapsed Metastatic Solid Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Early research (Phase 1)Temporarily pausedNCT04222309
What this trial is testing

Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)

Who this might be right for
GliomaGlioma, MalignantGlioblastoma+4 more
Northwell Health 10
Not applicableStudy completedNCT01773447
What this trial is testing

Set-back Suture Versus Traditional Vertical Mattress Suture

Who this might be right for
Basal Cell CarcinomaSquamous Cell CarcinomaMelanoma
University of California, Davis 47
Not applicableStudy completedNCT03197636
What this trial is testing

Co-stimulatory Markers and Vitamin D Status in Anti-PD1 Treated Melanoma Patients

Who this might be right for
Malignant Melanoma
Aarhus University Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00005971
What this trial is testing

Flavopiridol in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Melanoma (Skin)
NCIC Clinical Trials Group 17
Testing effectiveness (Phase 2)Ended earlyNCT01562899
What this trial is testing

MEK162 and AMG 479 in Patients With Selected Solid Tumors

Who this might be right for
Metastatic Pancreatic AdenocarcinomaBRAF Mutated Melanoma
Pfizer 77
Testing effectiveness (Phase 2)Study completedNCT00041587
What this trial is testing

Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma

Who this might be right for
Malignant GliomaGlioblastoma MultiformeAnaplastic Astrocytoma+1 more
INSYS Therapeutics Inc 80
Very early researchLooking for participantsNCT07076472
What this trial is testing

Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma

Who this might be right for
Progressive GlioblastomaRecurrent Glioblastoma
Mayo Clinic 8
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07521657
What this trial is testing

Efficacy of Mirdametinib Alone or Combination With Radiotherapy for Germline and Sporadic NF1-Altered High-Grade Glioma

Who this might be right for
Neurofibromatosis 1 (NF1)
University of Alabama at Birmingham 55
Testing effectiveness (Phase 2)Study completedNCT02655601
What this trial is testing

Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001

Who this might be right for
High Grade GliomaAstrocytoma, Grade IIIGlioblastoma
BioMimetix JV, LLC 177
Not applicableStudy completedNCT06613230
What this trial is testing

Improved Early Diagnosis in Female Pelvic Cancer With OC Detect

Who this might be right for
Ovarian CancerEndometrial CancerBreast Cancer+3 more
Region Skane 490
Next Page